Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation.
暂无分享,去创建一个
[1] A. Gingras,et al. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] I. Stansfield,et al. An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast , 2012, Molecular biology of the cell.
[3] P. Blackshear,et al. Control of PHAS-I by Insulin in 3T3-L1 Adipocytes , 1995, The Journal of Biological Chemistry.
[4] E. Krebs,et al. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Abraham,et al. Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.
[6] M. Mclaughlin,et al. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. , 1994, The Journal of biological chemistry.
[7] A. Nairn,et al. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] N. Sonenberg,et al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. , 1994, Science.
[9] A. Gingras,et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.
[10] T. Haystead,et al. Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes. , 1994, The Journal of biological chemistry.
[11] Paul Tempst,et al. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs , 1994, Cell.
[12] Stuart L. Schreiber,et al. A mammalian protein targeted by G1-arresting rapamycin–receptor complex , 1994, Nature.
[13] G. Thomas,et al. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Lawrence,et al. Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Kunz,et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression , 1993, Cell.
[16] N. Sonenberg,et al. eIF-4E Phosphorylation and the Regulation of Protein Synthesis , 1993 .
[17] N. Sonenberg,et al. mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.
[18] J. Avruch,et al. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.
[19] G. Crabtree,et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.
[20] R. Rhoads. Protein synthesis, cell growth and oncogenesis. , 1991, Current opinion in cell biology.
[21] J. Heitman,et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast , 1991, Science.
[22] S. Schreiber,et al. Chemistry and biology of the immunophilins and their immunosuppressive ligands. , 1991, Science.
[23] R. Jackson,et al. The novel mechanism of initiation of picornavirus RNA translation. , 1990, Trends in biochemical sciences.
[24] L A Herzenberg,et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] N. Sonenberg,et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.
[26] N. Sigal,et al. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. , 1990, Journal of immunology.
[27] R. Jagus,et al. Evaluation of protein phosphorylation state by a combination of vertical slab gel isoelectric focusing and immunoblotting. , 1989, Analytical biochemistry.
[28] S. P. Johnson,et al. Phosphorylation of the Saccharomyces cerevisiae equivalent of ribosomal protein S6 has no detectable effect on growth , 1987, Molecular and cellular biology.
[29] B. Moss,et al. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[30] N. Sonenberg,et al. Insertion mutagenesis to increase secondary structure within the 5′ noncoding region of a eukaryotic mRNA reduces translational efficiency , 1985, Cell.
[31] A. Shatkin. mRNA cap binding proteins: essential factors for initiating translation , 1985, Cell.
[32] V. Agol,et al. Differences between translation products of tick-borne encephalitis virus RNA in cell-free systems from Krebs-2 cells and rabbit reticulocytes: involvement of membranes in the processing of nascent precursors of flavivirus structural proteins. , 1984, Virology.
[33] V. Agol,et al. Complete translation of encephalomyocarditis virus RNA and faithful cleavage of virus‐specific proteins in a cell‐free system from Krebs‐2 cells , 1978, FEBS letters.
[34] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.